Synthetic Stem Cells Market report delivers a far-reaching market research on the current conditions of the industry, potential of the market in the present and the future prospects from various points of views. Market drivers and market restraints evaluated in this report gives clear understanding about how the product is getting utilized in the recent period and also offer estimations about the future usage
Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new research being highlighted as part of the Companys fourth annual Science Day. Modernas Science Day is designed to provide insight into the continued diverse efforts underway at Moderna to better understand how to use mRNA as medicines and vaccines and underscores the Companys continued commitment to basic science and innovation. Science Day gives us an opportunity to provide insights into the advancements in our platform science and our further understanding of how to use mRNA as both a vaccine and a medicine
New York, May 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell and Gene Therapy CROs Market by Type of Therapy, Scale of Operation, Preclinical Services Offered, Clinical Services Offered, and Geography : Industry Trends and Global Forecasts, 2021-2030" - https://www.reportlinker.com/p06076407/?utm_source=GNW Presently, over 30 cell and gene therapies have received marketing approval, while around 1,000 therapeutic leads are under evaluation. Considering the advantages of ATMPs, and their ability to address the underlying causes of several serious clinical conditions wherein small molecule drugs have been proven to be inadequate, the preference for such therapeutic modalities is on the rise. In fact, experts believe that, by 2030, 40 - 60 such products are likely to be approved in the US alone
In response to the technological advances of recent years, the International Society for Stem Cell Research today (May 26) released an updated version of its guidelines for basic and clinical research involving human stem cells and embryos. The ISSCRs changes include recommendations for using human embryo models, lab-derived gametes, and human-animal chimeras as well as an end to the widely accepted two-week maximum for growing human embryos in culture
By Jennifer WhitlockField Editor The roots of plants may hold the key to improving drought tolerance, according to researchers at the University of California (UC). For a decade, these university scientists have been creating an mRNA atlas of tomato plant roots, because the roots are where plants first detect drought and other environmental threats
Researchers from Tokyo Metropolitan University have been quantifying how different batches of mesenchymal stem cells respond to the mechanical stiffness of their environments.
Galway, Ireland and San Diego, USA, 17 May 2021 ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has entered into a research collaboration with the National University of Ireland,Galway(NUI Galway)which provides access to unique expertise in evaluating the cancer cell microenvironment in Acute Myeloid Leukaemia (AML) and targeting of AML stem cells in models mimicking the bone marrow microenvironment.The research will support the optimization of ONK Therapeutics dual-targeted NK cell therapy program, ONKT104, being developed for the treatment of AML. ONK Therapeutics will fund a year-long research program in the laboratory of Dr
By Sofia MoutinhoMay. 20, 2021 , 11:05 AM They are no bigger than sesame seeds, and they pulse with a hypnotic rhythm
Boston, MA, May 21, 2021 (GLOBE NEWSWIRE) -- Mass General Brigham today announced its selections for the sixth annual Disruptive Dozen, 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in the next few years. The technologies were featured as part of the World Medical Innovation Forum held virtually from Boston to examine GCTs potential to impact patient care including a range of diseases and health system opportunities
Recent Comments